Management Team
Anders Rylander
- CEO since 2011
Anders Morén
- CFO since 2023
Hanna Ritzén
- Chief Operating Officer, since 2022
Henrik Winther
- SVP Business Development since 2020
Hector Tamburini
- Head of US Operations since 2024
Helle Fisker
- VP Commercial since 2021
>4,500
Numbers of patients in studies
28
Publications
22
Pharma Projects